Skip to content

HEAL · NASDAQ · ETF

Global X HealthTech ETF (HEAL) Price, Holdings & Fees

$919.70+0.50%+$4.54End-of-day price as of Oct 9, 2026

Global X HealthTech ETF (HEAL) closed at $919.70 on Oct 9, 2026, up 0.50% from the previous close of $915.16.

Share price, past year

1Y +10.75%

52-week range $808.74 – $982.67. Daily closing prices.
Monthly closing prices
Last closing price of each month
DateClose
Oct 9, 2026$919.70
Sep 30, 2026$876.42
Aug 31, 2026$884.28
Jul 31, 2026$813.39
Jun 30, 2026$837.11
May 29, 2026$900.84
Apr 30, 2026$928.83
Mar 31, 2026$916.99
Feb 27, 2026$970.18
Jan 30, 2026$962.44
Dec 31, 2025$933.14
Nov 28, 2025$926.04
Oct 31, 2025$873.28

Key statistics

Expense ratio
0.50%
as of Mar 31, 2026
Net assets
$25M
as of May 31, 2026
Holdings
41
as of May 31, 2026
52-week range
$808.74 – $982.67

Global X HealthTech ETF's expense ratio is 0.50%: $50.00 a year on $10,000 invested.

Holdings

Global X HealthTech ETF held 41 investments worth $25.04M as of May 31, 2026. Its largest holding was DEXCOM, INC., at 4.89% of the fund.

Global X HealthTech ETF largest holdings by share of net assets
#Holding% of fundValue
1DEXCOM, INC.4.89%$1.22M
2IQVIA HOLDINGS INC4.72%$1.18M
3OSCAR HEALTH, INC.4.61%$1.15M
4FIDELITY COLCHESTER STR TR MONEY MKT GOV PORT4.46%$1.12M
5GE HEALTHCARE TECHNOLOGIES INC.4.17%$1.04M
6VEEVA SYSTEMS INC.4.13%$1.03M
7Koninklijke Philips N.V.4.12%$1.03M
8MASIMO CORPORATION4.07%$1.02M
9Pro Medicus Ltd3.96%$990.53K
10HIMS & HERS HEALTH, INC.3.90%$975.73K
11RESMED INC.3.78%$946.56K
12INTUITIVE SURGICAL, INC.3.77%$944.40K
13TEMPUS AI, INC.3.75%$938.54K
14IRHYTHM HOLDINGS, INC.3.50%$877.60K
15INSULET CORPORATION3.38%$846.88K
16Waystar Holding Corp.3.13%$783.00K
17Demant A/S3.11%$778.93K
18ALIBABA HEALTH INFORMATION TECHNOLOGY LIMITED2.73%$683.35K
19ALIGNMENT HEALTHCARE, INC.2.71%$679.35K
20Doximity Inc2.56%$640.48K
21TRANSMEDICS GROUP, INC.2.44%$611.99K
22PRIVIA HEALTH GROUP, INC.2.30%$576.58K
23Heartflow Inc1.99%$498.81K
24Hinge Health Inc1.77%$444.28K
25Recursion Pharmaceuticals Inc1.76%$439.74K

Top 25 of 41 holdings, as of May 31, 2026. Percentages are of the fund's net assets.

What the fund owns

Global X HealthTech ETF holdings by asset type
Asset type% of fund
Stocks99.83%
Cash and short-term investments4.46%
Global X HealthTech ETF holdings by country, largest 7
Country% of fund
United States87.34%
Australia5.63%
Netherlands4.12%
Denmark3.11%
Hong Kong2.73%
Sweden0.76%
South Korea0.60%

Shares of net assets from the fund's N-PORT report. Funds that borrow can add up to more than 100%, with borrowing (such as repurchase agreements) shown as a negative share.

Monthly total returns

Over the 3 months to May 31, 2026, Global X HealthTech ETF's total return was −6.04%, as reported to the SEC.

Global X HealthTech ETF monthly total returns
MonthTotal return
May 31, 2026−10.95%
Apr 30, 2026+6.44%
Mar 31, 2026−0.87%

The fund's own total returns as reported to the SEC (N-PORT), including reinvested distributions. Not the sample prices above.

Fund profile

Name
Global X HealthTech ETF
Ticker
HEAL
Exchange
NASDAQ
Fund type
ETF
Trust
Global X Funds
SEC series ID
S000069056
SEC CIK
0001432353
Fractional shares
Yes

Recent SEC filings

Shareholder reports and prospectuses are filed by Global X Funds, the trust behind Global X HealthTech ETF, and cover all of its funds.

Frequently asked questions

What is HEAL's price?

Global X HealthTech ETF (HEAL) closed at $919.70 on Oct 9, 2026, up 0.50% from the previous close of $915.16.

What is HEAL's expense ratio?

Global X HealthTech ETF's expense ratio is 0.50%: $50.00 a year on $10,000 invested.

What does HEAL hold?

Global X HealthTech ETF held 41 investments worth $25.04M as of May 31, 2026. Its largest holding was DEXCOM, INC., at 4.89% of the fund. Its five largest holdings were DEXCOM, INC., IQVIA HOLDINGS INC, OSCAR HEALTH, INC., FIDELITY COLCHESTER STR TR MONEY MKT GOV PORT, GE HEALTHCARE TECHNOLOGIES INC..

How has HEAL performed?

Over the 3 months to May 31, 2026, Global X HealthTech ETF's total return was −6.04%, as reported to the SEC.

Sources and methodology

Holdings, net assets and monthly returns come from the fund's N-PORT filing with the SEC, as of May 31, 2026 (filed Jul 29, 2026). The expense ratio is from the fund's prospectus or shareholder report, as of Mar 31, 2026. Prices are generated sample data for development. Data sources and disclosures